Q32 Bio Inc. Additional Paid in Capital, Common Stock
Q32 Bio Inc. (FIXX) had Additional Paid in Capital, Common Stock of $615.09 million as of 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Balance Sheet
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2024-03-13
- 2023-12-31: Additional Paid in Capital, Common Stock $615.09M.
- 2022-12-31: Additional Paid in Capital, Common Stock $607.51M.
- 2022-09-30: Additional Paid in Capital, Common Stock $604.35M.
- 2022-06-30: Additional Paid in Capital, Common Stock $601.44M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2023-12-31 | $615.09M 10-K · filed 2024-03-13 | |
| 2022-12-31 | $607.51M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $604.35M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $601.44M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $598.27M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $593.78M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $589.12M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $584.51M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $530.29M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $524.36M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $468.80M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $465.03M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $461.56M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $457.99M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $433.07M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $430.43M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $293.87M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $292.19M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $291.17M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $290.44M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $1.26M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $800.00K 10-K · filed 2019-03-12 | $799.86K 10-Q · filed 2018-05-14 |